Skip to main content

Table 1 Characteristics of the study population according to serum 25-hydroxyvitamin D concentrations (n = 4345)

From: Association of serum 25-hydroxyvitamin D concentrations with all-cause and cardiovascular mortality among US adults with prehypertension: a prospective cohort study

Characteristics

Severe deficiency

Moderate deficiency

Insufficient

Sufficient

p-values

Adjusted p-values

Serum 25(OH)D concentrations

 < 25 nmol/L

25–49.9 nmol/L

50–74.9 nmol/L

 ≥ 75 nmol/L

  

Sample size

201

1245

1694

1205

  

Age, years

38.7 ± 15.2

42.6 ± 15.5

44.9 ± 15.6

49.5 ± 16.7

 < 0.0001

0.0018

Men, n (%)

115 (56.2)

757 (59.8)

1124 (66.0)

677 (55.3)

 < 0.0001

0.0018

Ethnicity, n (%)

    

 < 0.0001

0.0018

 Hispanic

39 (18.5)

382 (21.5)

519 (16.6)

180 (5.7)

  

 White

25 (19.4)

330 (47.6)

800 (70.8)

850 (87.4)

  

 Black

115 (50.4)

401 (22.6)

227 (6.6)

83 (2.5)

  

 Other

22 (11.7)

132 (8.3)

148 (6.0)

92 (4.5)

  

Education, n (%)

    

 < 0.0001

0.0018

 Less than high school

53 (21.9)

334 (20.6)

457 (18.1)

221 (12.6)

  

 High school

56 (29.3)

317 (25.3)

365 (21.9)

260 (20.8)

  

 More than high school

92 (48.8)

594 (54.1)

872 (60.0)

724 (66.6)

  

Marital status, n (%)

    

 < 0.0001

0.0018

 Married

81 (40.5)

685 (55.9)

1102 (66.2)

789 (69.4)

  

 Separated

42 (20.1)

237 (17.8)

297 (15.6)

250 (16.7)

  

 Never married

78 (39.4)

323 (26.3)

295 (18.3)

166 (13.9)

  

Smoking status, n (%)

    

 < 0.0001

0.0018

 Current

68 (36.4)

333 (26.4)

373 (22.5)

233 (18.5)

  

 Former

25 (10.2)

220 (17.6)

426 (24.3)

335 (28.4)

  

 Never

108 (53.5)

692 (56.0)

895 (53.2)

637 (53.1)

  

Drinker, n (%)

141 (73.4)

937 (78.9)

1313 (81.6)

948 (84.3)

 < 0.0001

0.0018

Overweight/obesity, n (%)

148 (71.3)

963 (78.7)

1315 (79.1)

773 (66.1)

 < 0.0001

0.0018

Diabetes, n (%)

15 (5.9)

169 (10.7)

151 (6.7)

88 (4.9)

 < 0.0001

0.0018

Hypercholesterolemia, n (%)

23 (12.6)

256 (19.8)

398 (24.5)

381 (31.1)

 < 0.0001

0.0018

Heart failure, n (%)

4 (1.4)

21 (1.7)

16 (0.8)

20 (1.1)

 < 0.0001

0.0018

Coronary heart disease, n (%)

3 (1.1)

20 (1.2)

29 (1.7)

32 (1.6)

 < 0.0001

0.0018

Stroke, n (%)

2 (0.7)

18 (1.5)

21 (1.0)

26 (1.5)

 < 0.0001

0.0018

Cancer, n (%)

6 (4.7)

49 (4.1)

118 (7.2)

152 (11.9)

 < 0.0001

0.0018

Sedentary activity, hours/d

6.5 ± 3.2

6.3 ± 3.5

6.0 ± 3.3

5.9 ± 3.3

0.0064

0.1152

Total energy intake, kcal/d

2116.7 ± 1057.2

2225.0 ± 947.1

2278.8 ± 874.8

2263.0 ± 967.4

0.1631

0.1631

Sodium intake, mg/d

3424.0 ± 1713.1

3718.9 ± 1725.0

3736.4 ± 1593.7

3651.3 ± 1706.6

0.1159

0.1227

Potassium intake, mg/d

2375.0 ± 1103.0

2563.7 ± 1063.9

2790.0 ± 1088.9

2975.1 ± 1189.5

 < 0.0001

0.0018

Vitamin D supplement use, n (%)

17 (11.3)

157 (12.5)

488 (28.3)

629 (52.1)

 < 0.0001

0.0018

  1. Values are presented as weighted mean ± SD or frequency (weighted percentage) when appropriate
  2. Adjusted p-values were assessed by bonferroni method